What are key nursing points when educating patients about urinary function during cancer treatment?

• A. Monitor for urinary changes (dysuria, frequency, hematuria), maintain hydration, manage side effects, coordinate with oncology, assess for urinary incontinence due to treatment
• B. Ignore hydration
• C. Rely only on chemotherapy
• D. Avoid discussing urinary symptoms

Answer: (A)

Educating patients about urinary function during cancer treatment centers on proactive monitoring of what changes might occur, supporting the urinary system, managing related symptoms, coordinating care with the oncology team, and assessing for treatment‑related incontinence. Look for urinary changes such as dysuria, increased frequency or urgency, and hematuria, which can signal bladder irritation, infection, hemorrhagic cystitis, or other treatment‑related effects. Encouraging adequate hydration helps maintain kidney function, dilutes irritants in the urine, and supports bladder health, while also making it easier to detect problems early. Addressing side effects that accompany urinary symptoms—pain, urgency, frequency, nocturia—through comfort measures, appropriate medications, and bladder‑care strategies improves tolerance of treatment and quality of life. Coordinating with oncology ensures that education is aligned with the specific therapy being received, so clinicians can monitor for nephrotoxicity or bladder toxicity and adjust plans as needed. Finally, assess for incontinence related to surgery or pelvic radiation and provide or refer for appropriate interventions, such as bladder training or pelvic floor therapy, plus practical protections if leakage occurs. This comprehensive approach helps patients stay informed, safe, and engaged in their care rather than missing early signs of trouble.